Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2005 Q2- Text added to 2005 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
New words:
alive, announced, antitumor, bring, concurrence, confidence, dose, fashion, fill, follicular, HEPLISAV, histologically, lower, lymphoma, Mechanistic, mid, monoclonal, NHL, Pasteur, preapproval, progression, prophylactic, proportion, relevant, renal, Rituximab, shelf, sooner, therapy, TOLAMBA, toxicity, unqualified
Removed:
acting, began, concentrated, concentration, consolidation, disrupt, influence, influencing, merger, perception, successful
Valuein 2005 Q2 filing- Value in 2005 Q3 filing
Original filings
Filing view